The authors report the results obtained from the treatment of 13 cases of myeloma by cyclic chemotherapy (melphalan) applied after cellular synchronization with vincristine. The clinical results (maximum 2 years after treatment) were good in 11 cases out of 13. The following laboratory values quickly returned to normal: sedimentation and calcaemia, but there was little change in the immunoglobulins.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[cyclical chemotherapy
4
chemotherapy myeloma
4
myeloma cell
4
cell synchronization
4
synchronization therapeutic
4
therapeutic trial
4
trial apropos
4
apropos cases]
4
cases] authors
4
authors report
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!